MEDS insider filings

TRxADE HEALTH, INC — 34 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-05-28. Screen MEDS transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for MEDS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — TRxADE HEALTH, INC

FiledFormInsiderReported transactionsSource
2024-05-284/APatel Prashant — Interim CFO and Director, DirectorGrant/award (A): 10,000 @ $0EDGAR
2024-05-284/AAJJARAPU SURENDRA K — Chairman and CEO, DirectorGrant/award (A): 10,000 @ $0EDGAR
2024-01-164Patel Prashant — Interim CFO and Director, DirectorGrant/award (A): 150,000 @ $0EDGAR
2024-01-164AJJARAPU SURENDRA K — Chairman and CEO, DirectorGrant/award (A): 150,000 @ $0EDGAR
2023-02-244Huffman Janet — CFO, PAO, PFOGrant/award (A): 50,000 @ $0EDGAR
2023-01-204PETERSON MICHAEL L — DirectorGrant/award (A): 100,000 @ $0 · Grant/award (A): 135,802 (derivative) @ $0EDGAR
2022-12-304Newell A. Jeffrey — DirectorGrant/award (A): 79,062 @ $0EDGAR
2022-09-164Patel Prashant — President and COO, Director, 10% ownerGrant/award (A): 8,620 @ $0EDGAR
2022-09-164Huffman Janet — CFO, PAO, PFOGrant/award (A): 21,551 @ $0EDGAR
2022-09-164Fell Donald G. — DirectorGrant/award (A): 54,525 @ $0EDGAR
2022-09-164AJJARAPU SURENDRA K — CEO, Director, 10% ownerGrant/award (A): 51,724 @ $0EDGAR
2022-09-164POPE CHARLES L — DirectorGrant/award (A): 54,525 @ $0EDGAR
2022-08-294Fell Donald G. — DirectorPurchase (P): 1,500 @ $1.08EDGAR
2022-05-234AJJARAPU SURENDRA K — CEO, Director, 10% ownerPurchase (P): 10,000 @ $13,000EDGAR
2022-05-234/AAJJARAPU SURENDRA K — CEO, Director, 10% ownerPurchase (P): 10,000 @ $1.30EDGAR
2022-05-184Fell Donald G. — DirectorPurchase (P): 2,000 @ $1.26EDGAR
2022-04-044Doss Howard A.Holdings only — no transactions reportedEDGAR
2021-06-224PETERSON MICHAEL LSale (S): 900 @ $4.45EDGAR
2021-06-044Jennings Christine L. — DirectorGrant/award (A): 10,912 @ $3.78EDGAR
2021-06-024Tenaerts PamelaDisposition to issuer (D): 8,041 @ $0EDGAR
2021-06-024PETERSON MICHAEL LDisposition to issuer (D): 8,041 @ $0EDGAR
2021-06-024POPE CHARLES L — DirectorGrant/award (A): 10,912 @ $3.78EDGAR
2021-05-064Fell Donald G. — DirectorGift (G): 2,250 @ $0 · Gift (G): 300 @ $0EDGAR
2021-04-204Tenaerts Pamela — DirectorGrant/award (A): 10,721 @ $5.13EDGAR
2021-04-204Patel Prashant — President, Director, 10% ownerSale (S): 7,500 @ $4.39EDGAR
2021-04-204Fell Donald G. — DirectorGrant/award (A): 10,721 @ $5.13EDGAR
2021-04-204PETERSON MICHAEL L — DirectorSale (S): 900 @ $4.68 · Grant/award (A): 10,721 @ $5.13EDGAR
2021-04-154Fell Donald G. — DirectorSale (S): 500 @ $0.42 · Sale (S): 500 @ $0.30 · Sale (S): 4 @ $0.25 · Sale (S): 800 @ $0.44 · Sale (S): 400 @ $0.37 · Sale (S): 3 @ $0.26 · +16 moreEDGAR
2021-04-154/AFell Donald G. — DirectorSale (S): 500 @ $5.30EDGAR
2021-04-154/AFell Donald G. — DirectorGrant/award (A): 8,987 @ $6.12EDGAR
2020-12-164Tenaerts Pamela — DirectorSale (S): 800 @ $5.30EDGAR
2020-12-164Patel Prashant — President, Director, 10% ownerSale (S): 7,500 @ $5.29EDGAR
2020-12-154Fell Donald G. — DirectorSale (S): 500 @ $5.30EDGAR
2020-12-154PETERSON MICHAEL L — DirectorSale (S): 1,800 @ $5.26EDGAR

Recent 8-K events — TRxADE HEALTH, INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-198-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-038-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-198-K2.02 — Results of Operations and Financial Condition
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-078-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-208-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-298-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-05-228-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-058-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-018-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MEDS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs